Overview: Active Vitamin B12 TestIntroduction: The Active Vitamin B12 Test measures active B12 to diagnose deficiency, causing anemia or fatigue. Aligned with 2023 ASH guidelines, it uses biochemical methods for high specificity, supporting blood disorder screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected vitamin B12 deficiency.
Other Names: Active B12 Assay, Holotranscobalamin Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Active B12 testing began in the 2000s with nutritional research. Biochemical methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Measures active B12 to diagnose deficiency, guides treatment, and evaluates patients with anemia or fatigue.
Test Parameters: 1. Holotranscobalamin Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of anemia, fatigue, or nutritional deficiencies.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document anemia, fatigue, or history of nutritional deficiencies. Include current medications, especially B12 supplements.
Consent: Written consent required, detailing the tests purpose, vitamin B12 deficiency implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to measure holotranscobalamin levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for B12 deficiency diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Recent B12 supplementation may alter levels.
Clinical Significance: Low holotranscobalamin confirms B12 deficiency, guiding supplementation therapy. Normal levels may require methylmalonic acid or homocysteine testing.
Specialist Consultation: Consult a hematologist or nutritionist for result interpretation and treatment planning.
Additional Supporting Tests: Methylmalonic acid, homocysteine, or CBC to confirm B12 deficiency diagnosis.
Test Limitations: Non-specific for deficiency cause; clinical correlation is needed. Sample quality affects sensitivity.
References: ASH Hematology Guidelines, 2023; Blood, Carmel R, 2022.
